NAUT · Nautilus Biotechnology, Inc.
$0.95
+0.05 (+5.79%)
At close · Aug 21
Market Cap
$121.30M
Shares
127.08M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-28 | — | |
| 10-Q | 2026-07-28 | 2026-06-30 | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| 10-Q | 2026-04-28 | 2026-03-31 | |
| 8-K | 2026-04-28 | — | |
| DEF 14A | 2026-04-28 | 2026-06-17 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-10-28 | — | |
| 10-Q | 2025-10-28 | 2025-09-30 | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-06-23 | 2025-06-20 | |
| 8-K | 2025-05-02 | 2025-05-01 | |
| DEF 14A | 2025-04-29 | 2024-12-31 | |
| 8-K | 2025-04-29 | — | |
| 10-Q | 2025-04-29 | 2025-03-31 | |
| 8-K | 2025-02-27 | 2025-02-24 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-01-31 | 2025-01-27 | |
| 8-K | 2024-10-29 | — | |
| 10-Q | 2024-10-29 | 2024-09-30 | |
| 8-K | 2024-07-30 | — | |
| 10-Q | 2024-07-30 | 2024-06-30 | |
| 8-K | 2024-06-13 | — | |
| 8-K | 2024-04-30 | — | |
| 10-Q | 2024-04-30 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2023-12-31 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2023-12-14 | — | |
| 8-K | 2023-10-31 | — | |
| 10-Q | 2023-10-31 | 2023-09-30 | |
| 8-K | 2023-08-02 | — | |
| 10-Q | 2023-08-02 | 2023-06-30 | |
| 8-K | 2023-06-15 | 2023-06-14 | |
| 10-Q | 2023-05-02 | 2023-03-31 | |
| 8-K | 2023-05-02 | — | |
| DEF 14A | 2023-04-27 | 2023-06-14 | |
| 10-K | 2023-02-23 | 2022-12-31 | |
| 8-K | 2023-02-23 | — | |
| 8-K | 2022-11-01 | 2022-10-27 | |
| 8-K/A | 2022-11-01 | 2022-03-30 | |
| 10-Q | 2022-11-01 | 2022-09-30 | |
| 8-K | 2022-08-02 | — | |
| 10-Q | 2022-08-02 | 2022-06-30 | |
| 8-K | 2022-06-16 | 2022-06-14 | |
| 10-Q | 2022-05-03 | 2022-03-31 |
Showing 1–50 of 71 filings
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
86 filings
85 filers
Visit website
Investor relations